Management of Chronic Migraines
For chronic migraine management, first rule out medication overuse headache, then initiate preventive therapy with topiramate as first-line treatment, followed by onabotulinumtoxinA or CGRP monoclonal antibodies if topiramate fails, while addressing lifestyle factors and comorbidities. 1, 2
Initial Assessment and Diagnosis
- Chronic migraine is defined as headaches occurring on ≥15 days per month for at least 3 months, with migraine features on ≥8 days per month 1
- Key assessment elements:
- Headache frequency, intensity, and duration
- Medication use patterns to identify medication overuse headache (MOH)
- Presence of comorbidities (depression, anxiety, sleep disorders, obesity)
- Current lifestyle factors and triggers
Step 1: Rule Out Medication Overuse Headache
MOH frequently mimics chronic migraine and must be addressed first:
- Defined as headache occurring ≥15 days/month due to regular overuse of acute medications:
- Simple analgesics used >15 days/month
- Triptans or combination analgesics used >10 days/month 2
- Management approach:
Step 2: Implement Preventive Therapy
After ruling out MOH, initiate preventive medication:
First-line treatment:
- Topiramate (100 mg/day) - strongest evidence for chronic migraine 1, 2
- Advantages: may lead to weight loss, which is beneficial as obesity is a risk factor 2
- Monitor for cognitive side effects
Second-line treatments (if topiramate fails or is contraindicated):
OnabotulinumtoxinA - FDA-approved specifically for chronic migraine 1, 3
- Administered as multiple injections every 12 weeks
- Warning: monitor for potential adverse effects including swallowing/breathing problems 3
CGRP monoclonal antibodies (erenumab, fremanezumab, galcanezumab) 1
- Indicated when at least two other preventive medications have failed
- Newer treatment option with favorable side effect profile
Other preventive options with less robust evidence for chronic migraine:
- Beta blockers (propranolol 80-240 mg/day, timolol 20-30 mg/day) 2
- Amitriptyline (30-150 mg/day) - particularly useful if comorbid depression or sleep disturbances 2
- Divalproex sodium (500-1500 mg/day) 2
Step 3: Address Lifestyle Factors and Triggers
Implement comprehensive lifestyle modifications:
- Regular sleep schedule
- Consistent meal times and adequate hydration
- Regular exercise program (aerobic exercise 40 minutes, three times weekly) 2
- Stress management (yoga, cognitive-behavioral therapy, mindfulness) 2
- Limited caffeine intake 2
Step 4: Manage Comorbidities
Addressing comorbid conditions improves treatment outcomes:
- Depression and anxiety: consider amitriptyline if present
- Sleep disorders: improve sleep hygiene, consider amitriptyline
- Obesity: encourage weight loss, consider topiramate
- Chronic pain conditions: address with appropriate therapies 1
Step 5: Acute Treatment Strategy
Even with preventive therapy, patients need effective acute treatment:
- NSAIDs (aspirin 650-1000 mg, ibuprofen, naproxen) for mild attacks 2
- Triptans for moderate-severe attacks 2
- Combination of triptan + NSAID for optimal efficacy 2
- Antiemetics for attacks with prominent nausea/vomiting 2
Step 6: Monitoring and Follow-up
- Use headache diary to track:
- Frequency and severity of attacks
- Medication use and efficacy
- Potential triggers 2
- Evaluate treatment effectiveness after 2-3 months 2
- Consider treatment modification if inadequate response
- Preventive treatment should continue for at least 3-4 months to determine efficacy 2
When to Refer to Specialist Care
Referral to neurology/headache specialist is indicated when:
- Diagnosis is uncertain
- Treatment is ineffective despite appropriate interventions
- Significant comorbidities complicate management
- Medication overuse cannot be managed in primary care 1, 2
Common Pitfalls to Avoid
- Failing to identify and address medication overuse headache
- Inadequate duration of preventive therapy (minimum 3-4 months needed)
- Not addressing lifestyle factors and triggers
- Overlooking important comorbidities
- Not using headache diaries to monitor treatment response
- Premature discontinuation of preventive therapy